JP2012502975A5 - - Google Patents

Download PDF

Info

Publication number
JP2012502975A5
JP2012502975A5 JP2011527444A JP2011527444A JP2012502975A5 JP 2012502975 A5 JP2012502975 A5 JP 2012502975A5 JP 2011527444 A JP2011527444 A JP 2011527444A JP 2011527444 A JP2011527444 A JP 2011527444A JP 2012502975 A5 JP2012502975 A5 JP 2012502975A5
Authority
JP
Japan
Prior art keywords
pyrazole
carboxamide
cyanophenyl
isopropyl
cyclopropyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2011527444A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012502975A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2009/054038 external-priority patent/WO2010032200A1/en
Publication of JP2012502975A publication Critical patent/JP2012502975A/ja
Publication of JP2012502975A5 publication Critical patent/JP2012502975A5/ja
Withdrawn legal-status Critical Current

Links

JP2011527444A 2008-09-18 2009-09-16 治療において有用なアミド化合物 Withdrawn JP2012502975A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9790208P 2008-09-18 2008-09-18
US61/097,902 2008-09-18
PCT/IB2009/054038 WO2010032200A1 (en) 2008-09-18 2009-09-16 Amide compounds useful in therapy

Publications (2)

Publication Number Publication Date
JP2012502975A JP2012502975A (ja) 2012-02-02
JP2012502975A5 true JP2012502975A5 (enExample) 2012-10-25

Family

ID=41269630

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011527444A Withdrawn JP2012502975A (ja) 2008-09-18 2009-09-16 治療において有用なアミド化合物

Country Status (20)

Country Link
US (2) US8232269B2 (enExample)
EP (1) EP2350017A1 (enExample)
JP (1) JP2012502975A (enExample)
KR (1) KR20110044304A (enExample)
CN (1) CN102159548A (enExample)
AP (1) AP2011005611A0 (enExample)
AU (1) AU2009294290B2 (enExample)
BR (1) BRPI0918935A2 (enExample)
CA (1) CA2735931A1 (enExample)
CL (1) CL2011000570A1 (enExample)
CO (1) CO6351734A2 (enExample)
DO (1) DOP2011000083A (enExample)
EA (1) EA201100368A1 (enExample)
EC (1) ECSP11010901A (enExample)
IL (1) IL211479A0 (enExample)
MA (1) MA32642B1 (enExample)
MX (1) MX2011002899A (enExample)
PE (1) PE20110793A1 (enExample)
WO (1) WO2010032200A1 (enExample)
ZA (1) ZA201102690B (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2831338C (en) * 2011-04-21 2018-07-17 Orion Corporation Androgen receptor modulating carboxamides
CA2842360C (en) * 2011-07-21 2020-07-07 The Regents Of The University Of California Targeting gli proteins in human cancer by small molecules
ES2733750T3 (es) 2012-02-17 2019-12-02 Eisai R&D Man Co Ltd Métodos y compuestos útiles en la síntesis de antagonistas del receptor de orexina-2
EP2700635A1 (en) 2012-08-20 2014-02-26 Basf Se 5-Trifluoromethylpyrazole amides having herbicidal activity
ES3007293T3 (en) 2013-01-23 2025-03-19 Univ California Targeting gli proteins in human cancer by small molecules
EP3290421B1 (en) 2013-02-22 2019-01-02 Pfizer Inc Combination of pyrrolo [2, 3 -d]pyrimidine derivatives with one or more additional agents as inhibitors of janus- related kinases (jak)
WO2014143617A1 (en) * 2013-03-14 2014-09-18 Teva Women's Health, Inc. Deuterium-enriched tanaproget and processes for its preparation
JP6585158B2 (ja) 2014-08-12 2019-10-02 ファイザー・インク ヤヌスキナーゼの阻害に有用なピロロ[2,3−d]ピリミジン誘導体
US20190321363A1 (en) * 2016-06-20 2019-10-24 Dr. Reddy's Laboratories Limited Process for the preparation of elagolix sodium and its polymorph
CN108623446A (zh) * 2017-03-24 2018-10-09 北京艾德旺科技发展有限公司 一种合成3,3-二氟环丁烷甲酸的方法
EP3946606B1 (en) 2019-03-27 2025-01-01 Insilico Medicine IP Limited Bicyclic jak inhibitors and uses thereof
AU2020373913B2 (en) * 2019-10-28 2024-04-18 Shanghai Institute Of Materia Medica, Chinese Academy Of Sciences Five-membered heterocyclic oxocarboxylic acid compound and medical use thereof
CN118660877A (zh) * 2022-05-12 2024-09-17 西北农林科技大学 二苯基吡唑类化合物的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1874732A1 (en) * 2005-04-20 2008-01-09 Pfizer Limited Pyrazole derivatives as progesterone receptor antagonists
EP1932833B1 (en) * 2005-10-07 2012-08-01 Kissei Pharmaceutical Co., Ltd. Nitrogenated heterocyclic compound and pharmaceutical composition comprising the same

Similar Documents

Publication Publication Date Title
JP2012502975A5 (enExample)
AU2018360854B2 (en) Modulators of the integrated stress pathway
CN109641854B (zh) 整合应激通路的调节剂
RU2345070C2 (ru) Производные аминоиндазолов в качестве лекарственных средств, способ их получения и содержащие их фармацевтические композиции
JP6556146B2 (ja) 複素環化合物
AU2013354226B2 (en) Novel benzimidazole derivatives as EP4 antagonists
JP2013516415A5 (enExample)
JP6914933B2 (ja) ヤヌスキナーゼ、並びにその組成物及びその使用
JP2014511869A5 (enExample)
KR20120062839A (ko) 단백질 키나제 억제제로서의 화합물 및 조성물
JP2019077725A5 (enExample)
RU2016112952A (ru) Производные индола и индазола
JP2020503299A5 (enExample)
RU2018127315A (ru) Индуцирующие апоптоз средства для лечения злокачественной опухоли и иммунологических и аутоиммунных заболеваний
JP2014139226A5 (enExample)
RU2011125314A (ru) Новое производное пиразол-3-карбоксамида, обладающее антагонистической активностью в отношении рецептора 5-нт2в
JP2010514689A5 (enExample)
JP2011524363A5 (enExample)
JPWO2015016206A1 (ja) 複素環化合物
JP2012525431A5 (enExample)
JP2016510035A5 (enExample)
JP2019504901A5 (enExample)
RU2007100136A (ru) Соединения и композиции в качестве ингибиторов протеинкиназы
JP2016518434A (ja) スルファモイルピロールアミド誘導体およびb型肝炎を処置するための医薬品としてのその使用
JP6900491B2 (ja) ピラゾロピリミジン化合物及びその使用方法